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Infection with HIV, and oftentimes coinfection with TB, complicates the care of severely malnourished children in sub-Saharan
Africa. These superimposed infections challenge clinicians faced with a population of malnourished children for whose care
evidence-based guidelines have not kept up. Even as the care of HIV-uninfected malnourished children has improved dramatically
with the advent of community-based care and even as there are hopeful signs that the HIV epidemic may be stabilizing or
ameliorating, significant gaps remain in the care of malnourished children with HIV. Here we summarize what is currently known,
what remains unknown, and what remains challenging about how to treat severely malnourished children with HIV and TB.
1. Background
An estimated 19 million children are severely wasted in
developing countries—malnutrition is responsible for 11%
of the total global disease burden and 35% of child deaths
worldwide [1]. In some regions, notably sub-Saharan Africa,
human immunodeficiency virus (HIV) infection poses an
added challenge to the care of malnourished children.
While the clinical context and interventions for many
common causes of childhood mortality worldwide have
been addressed over the last decade [2], the management
of severe wasting disease and malnutrition in children—
particularly in those infected with HIV and/or tuberculosis
(TB)—remains poorly addressed [3]. This population of
HIV- and TB-infected malnourished children is in many
ways very different from the uninfected population for which
international malnutrition guidelines [4–6] were originally
developed.
In sub-Saharan Africa, the epidemiology of severe mal-
nutrition has shifted to one where an increasing percentage
of children requiring hospitalization is composed of those
who are HIV infected or HIV exposed—often coinfected
with TB—with case-fatality rates still as high as 20–50%
[7]. Meanwhile, ready-to-use therapeutic foods (RUTFs)
that facilitate effective home-based therapy have resulted
in recovery rates for uncomplicated severe malnutrition
approaching 90% [8–10], although the recovery rates remain
much lower for those children with HIV [11].
In this paper, we present some of the challenges and
unanswered questions in the management of malnourished
children with HIV (and often TB) and summarize our ap-
proach to managing these problems in the absence of clear
data to guide us.
2. TheMagnitude of the Problem
The average estimated HIV prevalence in 2009 for African
adults between the ages of 15 and 49 is about 4.7% [12],
with a range from 0.1% to 26% depending on the individual
country (Table 1). Meanwhile, there are 137 million children
under the age of 5 in sub-Saharan Africa, of whom 12.3
million are wasted. Meanwhile, some 2.3 million children
aged 0–14 in the region have HIV [13], and undoubtedly
there is significant overlap in these two populations. An
estimated 5% of the region’s under-five mortality is due to
HIV [14], but this is as high as 35% in South Africa [12].
Assessing the magnitude of TB incidence in children is
less straightforward. The incidence of TB in the under-five
age group can be estimated to be half of the adult male
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Table 1: HIV prevalence in adults 15–49 years old in Africa [12].
Prevalence of HIV Number of countries Country
0–0.9% 7 Algeria, Comoros, Eritrea, Madagascar, Mauritania, Niger, Senegal
1–4.9% 19
Angola, Benin, Burkina Faso, Burundi, Central African Republic, Chad, Congo, Coˆte
d’Ivoire, Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritius, Nigeria,
Rwanda, Sierra Leone, Togo
5–9.9% 6 Cameroon, Equatorial Guinea, Gabon, Tanzania, Kenya, Uganda
10–19.9% 6 Malawi∗, Mozambique∗, Namibia∗, South Africa∗, Zambia∗, Zimbabwe∗
20–30% 3 Botswana∗, Lesotho∗, Swaziland∗
Missing 5 Cape Verde, Democratic Republic of Congo, Ethiopia, Sao Tome and Principe, Seychelles
∗
These 9 countries account for 50% of the global burden of HIV-associated TB [15].
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Figure 1: The association between HIV prevalence and TB in sub-
Saharan Africa.
incidence and similar to the adult female incidence; following
this, then there are at least 330,000 cases of TB each year
in children under 5 in sub-Saharan Africa [16]. However,
the incidence of TB among HIV-positive children is almost
1600 per 100,000, with a 24-fold higher risk of developing
culture-confirmed TB in HIV-positive infants compared to
HIV-negative infants [17]. Taking this into account would
bring the total number of cases closer to 350,000 annually.
Some 30% of all culture-confirmed TB cases who have had
an HIV test are found to be HIV positive [17]. Given this and
the fact that adults with HIV have an approximately 10% risk
per year of developing TB, it is not surprising that countries
with high HIV prevalence also have higher prevalence of TB
[18] (Figure 1).
Children in sub-Saharan Africa who are HIV infected
or HIV exposed are significantly more likely to be stunted,
wasted, and underweight [19]. The high prevalence of
HIV and TB in sub-Saharan Africa has created a large
population of children who are malnourished and infected
with both HIV and TB. In the long run, the most effective
and efficient method of decreasing the population of HIV-
infected children withmalnutrition is an aggressive approach
to the prevention of mother-to-child transmission (PMTCT)
[20], and it is encouraging that a new emphasis has
been placed on eliminating new cases of HIV in children
[21]. A variety of implementation strategies to achieve this
goal are available, and there is opportunity for innovative
approaches to be developed locally. For example, Malawi has
recently embarked on an aggressive plan to treat all HIV-
positive pregnant and breastfeeding women with ART for life
(referred to as Option “B+”) [22]. The wide-scale rollout of
ART in Malawi in general has also been linked to decreasing
rates of TB [23], and we can anticipate that this benefit will
continue as more active approaches to HIV control continue
to expand, including more regular systematic tracking of
patients not yet on ART. Despite these gains, we will continue
to be faced with large numbers of malnourished children
withHIV—and often TB also—unless and until that laudable
goal is reached.
3. The Altered Clinical Presentation of
Malnutrition in Children Infected with HIV
There are a number of clinical features that may be helpful
in identifying those malnourished children who are also
infected with HIV [24]. While HIV-infected children can
present with either kwashiorkor (edematous malnutrition)
or marasmus (severe wasting), just as those without HIV,
a disproportionately larger number of children with HIV
present with marasmus. Relative to HIV-uninfected chil-
dren, malnourished children with HIV tend to be even
more stunted and underweight. They more often present
with severe oral and esophageal candidiasis, complicating
attempts at therapeutic feeding. Greater susceptibility to
a variety of infections, for example, cutaneous infections
from the skin breakdown often seen with kwashiorkor,
means they will often have protracted clinical courses and
require more aggressive antimicrobial therapy, wound care,
and have a higher caloric requirements. One of the most
challenging and frustrating complications faced is persistent
HIV-associated diarrhea, for which no specific therapy has
been developed and for which no clinical trial evidence
yet exists to guide optimal management. A diagnosis of
HIV should be strongly suspected in unusually young
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malnourished children (e.g., those under 6 months of age),
in unusually old children (e.g., those over 5 years of age),
and in those who do not respond appropriately to nutritional
interventions, in addition to the usual suspicion that arises if
a child presents with an opportunistic infection such as TB
or Pneumocystis jirovecii pneumonia (PCP).
Response to therapy is also less predictable and less
well-understood in HIV-infected children. Decreased food
intake leads to wasting, with an associated reduction in
organ system function and an increase in susceptibility to
environmental perturbations and stress [25]. Since most of
the metabolic responses described in severe malnutrition are
based on children without HIV, the responses in HIV-infected
malnourished children remain largely unknown [26]. When
TB or other infections are further superimposed, even less is
predictable [27].
4. Challenges in Community-Based Care for
Severely Malnourished Children with HIV
The vast majority of children with severe malnutrition can
and should be treated as outpatients [8, 9]. The advent
and widespread acceptance of RUTF has revolutionized the
care of severely malnourished children over the last decade,
making it possible to treat children in the community
setting. This has relieved much of the burden on inpatient
nutritional rehabilitation units (NRUs), whose care can
then be reserved for children with complications such as
superimposed infections or protracted diarrhea requiring
intensive rehydration. Community-based management is
now considered the standard of care for children with
uncomplicatedmalnutrition—which accounts formore than
90% of cases of severe malnutrition—who demonstrate an
appropriate appetite and have reliable caregivers [10].
In our practice, we have observed that a large per-
centage of HIV-positive children have an episode of severe
malnutrition as their first AIDS-defining illness. Given that
children with HIV and severe malnutrition invariably have
lower nutritional recovery and higher mortality rates than
their HIV-negative counterparts [28] and that those who
do recover take longer to achieve nutritional recovery [10],
it is imperative that voluntary HIV testing and counseling
be offered to all children with severe malnutrition in order
to identify those with HIV. Children diagnosed with HIV
should then be referred for PCP prophylaxis and ART as soon
as possible—there is no evidence to indicate that delaying
ART is of benefit to this population of children, with regards
to either decreasing rates of the immune reconstitution
inflammatory syndrome (IRIS) or to the adverse metabolic
effects of ART. In fact, decreasing the metabolic and energy
demands placed on the child’s physiology due to uncon-
trolled HIV will in general speed up nutritional recovery as
well [29].
In practice, there is often a delay in initiating ART in
the community setting, due to delays in testing, counseling,
drug procurement, and other steps in the process. Ideally,
malnutrition and HIV services should always be available,
complementary, and well coordinated in any normal daily
clinic—rather than caretakers being required to return on
multiple separate occasions to have each illness addressed
individually. While this may initially be challenging in large
health centers, the strong link betweenmalnutrition andHIV
makes this a worthy goal to work towards in our opinion.
Linking these services together, providing efficient clinics,
and decreasing the number of follow-up visits necessary
for routine care are all efforts that may help increase re-
tention and decrease the number of children lost to fol-
lowup.
5. Challenges in the Hospital Care of
Severely Malnourished Children with HIV
In the past, NRUs typically admitted sick severely malnour-
ished children mostly during periods of food insecurity
or in the postweaning period [30]. In sub-Saharan Africa,
we now admit many HIV-infected malnourished children
outside of these traditionally high-risk periods. These chil-
dren frequently present with many superimposed infections,
including (persistent) diarrhea, pneumonia, PCP, TB [31],
extensive cutaneous infections, and oral and gastrointestinal
candidiasis [32]. Case fatality rates are high in these children,
especially those with profuse diarrhea, and their response
to standard management protocols is poor [33]. Extremely
wasted and stunted adolescents, previously seen only rarely
outside the setting of famine, are now admitted frequently
for nutritional recovery and often present with chronic HIV-
related pathology such as chronic lung disease [34]. The
percentage of children who are readmitted has also increased
from 1-2% to more than 10% [35].
In Zambia and Malawi, for example, more than half of
patients admitted to many NRUs these days are HIV positive,
with case fatality rates of 40% or higher [31, 36]. Mortality in
severemalnutrition is already known to be elevated whenever
a child presents with superimposed infections [37, 38] and
metabolic maladaptation.
Since early in-hospital mortality is high [35], improve-
ments in initial treatment strategies depend on improved
knowledge of the most common causes of infection and
antibiotic sensitivities [39], pharmacokinetics of anti-infec-
tive medications in malnourished children, and potentially
complex drug interactions and toxicities (e.g., ART and
anti-TB therapy [40]). Bacterial susceptibility to first-line
antibiotic treatment varies between centers, and the choice
of empiric antimicrobials needs to be modified to suit local
resistance patterns [39]. The effect of widespread usage of
co-trimoxazole for PCP prophylaxis is already leading to
resistance among the most common pathogens [41, 42]. In
our setting, we see nearly 100% resistance to co-trimoxazole
by Streptococcus pneumoniae [43], leading to increased use of
second-line agents.
The metabolic and nutritional needs of HIV-infected
children are not well known [44, 45]. In HIV-uninfected
malnourished children, appetite is useful to guide nutritional
rehabilitation, but this seems not to be the case in HIV-
infected children since persistent anorexia is common.World
Health Organization (WHO) guidelines for the manage-
ment of children hospitalized with severe malnutrition
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[4, 5] provide little specific guidance for the treatment
of malnourished children with HIV [46]. Evidence from
clinical trials on how the management of severe malnutrition
should be modified for children with HIV is lacking, and
treatment protocols remain based almost entirely on expert
opinion and extrapolation from other populations. Given
this absence of evidence, it is our practice to initially stabilize
children with milk-based formulas such as F-75 [4]. These
children are generally ill enough to require urgent stabi-
lization of other physiological parameters as well, including
correction of hypoglycemia, hypothermia, dehydration, and
electrolyte imbalances. The use of empiric antibiotics and
antihelminthic medication for presumed active infections
and a presumed immune compromised state is often advo-
cated as well [5]. After this initial stabilization phase, feedings
can be advanced to a regimen of F-100 or RUTF, the
latter being preferred so that children can be discharged to
complete their care at home (thereby reducing crowding in
the ward and the risk of nosocomial infections) that much
sooner [9]. Unlike those without HIV, children with HIV
frequently have difficulty tolerating an advancement of their
feedings, and case fatality rates remain high during this
period [47]. Evidence on the optimal feeding regimen to be
used for HIV-infected children is lacking, and the choice is
thus generally based on local preference and resources, with
consideration given to the rate of weight gain and to adverse
events such as persistent hypoglycemia and an increase in
osmotic diarrhea or clinical signs of heart failure.
Suitable feeding and rehydration regimens are still
needed for the severe diarrhea commonly observed prior
to and during rehabilitation of HIV-infected severely mal-
nourished children, which is often associated with hypo-
glycemia [48, 49] and high case fatality rates [33, 50]. In
the past, adequate treatment regimens were developed for
HIV-uninfected children to reduce diarrheal morbidity and
mortality, induce catch-up growth, and improve nutritional
outcomes [51]. Modified or improved rehydration regimens
for HIV-infected children in this context may be helpful,
although no specific regimens are available at this time.
The spectrum of organisms associated with bacteremia
in this population [39, 52, 53] supports the importance
of mucosal translocation [54] as the inciting event. Maras-
mic children in one Zambian study showed lower CD4
counts compared to children with edematous malnutrition
(kwashiorkor), correlating with the protracted nature of
diarrhea observed in these children from opportunistic
enteropathogens such as Cryptosporidium [27]. Severe wast-
ing makes the clinical assessment of dehydration difficult,
so the presence of metabolic acidosis and lethargy are often
the clinical indications available to prompt resuscitation.
Unfortunately, there are also currently inadequate data on
the optimum regimen of supportive care (e.g., for shock) in
the malnourished child who has adapted to a reduced body
mass and organ system function [38, 55].
There remains variation in how severely malnourished
infants under 6 months of age are treated—explicit recog-
nition of this population is only slowly emerging, and
their mortality remains significantly higher than children
older than 6 months [1]. Appropriate dietary therapies are
needed for this increasing population, as the standard F-
75 and F-100 formulas are likely unsuitable [6]. The poor
socioeconomic background of these children oftenmakes the
use of commercial formulas for continued care as outpatients
impractical [56].
6. Challenges with Initiating ART in
Children with Severe Malnutrition
The optimal timing, regimen, and dosing of ART in the
inpatient population of children with complicated malnu-
trition remain guided primarily by expert opinion due to
a lack of prospective trial evidence [6, 29]. A number of
observational studies have shown that HIV-infected children
started on ART with more severe wasting have higher
rates of mortality than those with less wasting [57–59],
but no trial evidence exists to suggest that waiting until a
child’s nutritional status improves correlates with improved
outcomes. In fact, an important recent retrospective study
suggests that malnourished children who start ART promptly
have higher rates of nutritional recovery and weight gain
than those in whom ART is delayed [60].
A study in Zambia has shown that simply improving
the nutritional status of severely malnourished HIV-infected
children is insufficient to improve their immunological status
without ART [27]. In fact, excellent responses in CD4 count
and viral load have been demonstrated among those with
severe malnutrition who do receive ART, just as in those
with better baseline nutritional status [58]. In a cohort of
Zambian children where 59% of the children were initially
underweight and 72% stunted when starting ART, lasting
improvements in both weight and height were observed,
with weight-for-age Z-scores increasing during the first 6
months of treatment before stabilizing and with height-for-
age Z-scores increasing consistently over time. In this cohort,
children who were the most underweight experienced the
greatest increases in weight [61], likely a regression to
the mean phenomenon. This initial correction of wasting
followed by a lasting correction of stunting has been doc-
umented in the rehabilitative process of HIV-uninfected
malnourished children previously [51, 62]. In sum, it is
clear that severely malnourished children are indeed able
to respond appropriately to ART and nutritional supple-
mentation in terms of both nutritional and immunological
recovery. Therefore, these lifesaving medications should not
be delayed, and child health systems should embrace this in
a programmatic manner.
Admittedly, optimal timing for starting ART remains
controversial due to concerns over IRIS [36, 63]. One case-
control study comparing baseline factors related to the
development of IRIS did show that children with at least
one form of malnutrition (among stunting, wasting, and
underweight) were more likely to develop IRIS [64]. Never-
theless, there were no fatalities among those that developed
IRIS, and none required treatment interruptions from their
ART. At the same time, delays in initiating ART while
children are treated for TB has been shown to be detrimental
to overall clinical response and mortality, particularly in
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children with severe immune suppression [65]. Although the
clinical presentation is not typical of any knownART toxicity,
it is possible that ART initiated in children with severe
malnutrition and immunosuppression may lead to a clinical
deterioration and a syndrome mimicking kwashiorkor [63].
The low levels of circulating antioxidants and high levels of
lipid peroxidation products seen in untreated TB patients
[66] may be components of the perturbed physiologic
state malnourished children find themselves in. These may
further be part of their reductive adapted state, leading to a
kwashiorkor-like presentation of IRIS. In the end, the data on
this are relatively minimal and inconclusive, and ultimately
clinical judgment will have to be applied on a case-by-case
basis [67].
The alterations in body composition (decreased fat and
lean body mass) and metabolic functions (changes in renal,
hepatic, mitochondrial toxicity, and antioxidant capacity
among others) in children with severe malnutrition has
led to the concern that standard dosing of ART in these
children may be inappropriate. On the one hand, these
metabolic alterations perhaps lead to subtherapeutic drug
levels that may contribute to viral resistance, while on the
other hand these medications may be given at levels too toxic
for these fragile children to tolerate safely. Unfortunately,
only limited data exists to guide dosing recommendations for
ART in malnourished children. One observational study on
the pharmacokinetics of nevirapine in 37 Malawian children
showed that suboptimal dosing was not more prevalent
among moderately malnourished children [68]. As far as we
are aware, there are no studies that present data on toxicity
or other adverse effects from ART in severely malnourished
children nor is there any literature to guide which initial ART
regimen is best to start.
Further research evaluating the effects of ART in children
with severe malnutrition is clearly necessary, and initial stud-
ies are underway in Malawi. High-priority areas for study
include the optimal choice and timing of the initial ART
regimen, an assessment of toxicity and pharmacokinetics,
and an evaluation of the incidence and risk factors for
IRIS.
Implementation challenges in starting and maintaining
children on ART also persist and are found throughout
the chain of care in sub-Saharan Africa, especially in rural
areas. We have firsthand observed inconsistent supplies of
testing kits, reagents, and trained staff to provide voluntary
testing and counseling. Once testing is done and HIV-
infected children identified, there are often further delays
in referrals for group counseling, individual counseling,
and ultimately initiation of therapy—all of which require
trained staff and clinic facilities—and which often occur in
different locations and at different times, placing a further
burden on caretakers. Finally, supplies of ART and follow-
up clinical and laboratory monitoring remain inconsistent,
leaving patients vulnerable to treatment interruptions, which
could compound HIV control efforts by increasing rates of
viral drug resistance and spread. Aggressive investments in
expanding national HIV prevention and treatment programs
[69] must also address these and other challenges, which are
often faced most severely by rural health centers.
7. Challenges in Detecting Tuberculosis in
Malnourished Children with HIV
TB is notoriously difficult to diagnose in children. When
a child has both severe malnutrition and HIV, diagnostic
testing becomes even more difficult and, ultimately, also that
much more important [70]. The tuberculin skin test (TST),
long the first-line screening test, suffers from poor sensitivity
and specificity. Sensitivity suffers further when the child is
immunocompromised from HIV and severe malnutrition,
which blunt the type IV hypersensitivity reaction needed
to demonstrate a reactive TST. Given the high background
rate of TB in sub-Saharan Africa (with childhood HIV-TB
coinfection rates as high as 50% [71]), diagnosis is often
left to clinical judgment in those children with an exposure
history or with signs or symptoms or perhaps a chest
radiograph suggestive of TB [72]. Undoubtedly, this leaves
many children with TB undiagnosed and untreated, as well
as many children without TB treated unnecessarily. Local
health systems are unfortunately often too overburdened
to pursue contact tracing when a case of TB is identified,
but this remains an important component of the public
health approach tominimizing the spread of TB by providing
isoniazid preventive therapy (IPT) to children exposed to
adults and older siblings with active TB. IPT can also be
considered for all HIV-infected children and adults not
yet on ART, as has recently been recommended in Malawi
[69].
Aside from traditional means of improving the micro-
biological sensitivity of TB diagnosis in children such as
the string test or induced sputum [71], newer nucleic
acid amplification methods such as the Xpert MTB/RIF
test show great promise as screening tools for TB, even
in malnourished children from a population with a high
rate of HIV [73]. The relative affordability of these tests,
along with the speed with which results are available, has
the potential to revolutionize TB care and has recently
led to their endorsement by the WHO [74]. Nevertheless,
implementation of such testing is likely to remain years away
in most of sub-Saharan Africa, and thus clinicians will need
to continue to have a low threshold for diagnosis of TB
based on clinical and epidemiological suspicion. As with
the challenges involving ART described earlier, no evidence
exists on whether the dosing, timing, or medication choice
of anti-TB regimens need modification in this population of
children.
8. Looking Ahead: An Agenda for Research
Undernutrition, HIV, and TB all contribute to a large propor-
tion of child deaths worldwide, and this high mortality rate
is as avoidable as it is complex. As progress in the rollout of
ART and PMTCT accelerates in sub-Saharan Africa, there are
hopeful early signs that the number of children with severe
malnutrition and HIV will decrease in the future. Neverthe-
less, for the foreseeable time, this population of patients will
continue to challenge practitioners on the frontline, and the
evidence base for practice is limited.
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Table 2: Selected examples of open research questions in the care
of HIV-infected children with severe malnutrition.
ART in malnourished children
Appropriate medication regimen?
Changes based on maternal nevirapine exposure?
Appropriate dosing?
Optimal timing of initiating ART?
Adverse effects of ART in malnourished children?
Clinical or laboratory markers of adverse effects?
Risk factors or preventive measures for IRIS?
Interactions with TB medications?
Diarrhea in HIV-infected malnourished children
Optimal rehydration regimen?
Modified rehydration solutions (both oral and parenteral)?
Role for antibiotics or antiparasitics?
Role for zinc, glutamine, or probiotics?
Nutritional therapy in HIV-infected malnourished children
Need to modify screening criteria for enrollment into
nutritional care?
Need to modify criteria for younger (<6mos) and older
(>5 yrs) children?
Optimal initial choice of therapeutic food?
Optimal choice of therapeutic food during transition phase?
Need to modify criteria for graduation from nutritional care?
Adjuncts to nutritional therapy in HIV-infected malnourished
children
Vitamin A?
Empiric choice of antibiotics and antiparasitics?
TB diagnosis in HIV-infected malnourished children
Accuracy of traditional methods for diagnosis (e.g., chest X-ray,
TST)?
Accuracy of newer methods for diagnosis (e.g., Xpert
MTB/RIF)?
Operational challenges
How to implement the above findings and guidelines at each
level of care?
Prenatal and perinatal care?
Rural health center?
District hospital?
Central referral hospital?
A number of lingering questions remain that deserve
the attention of researchers in this setting (Table 2). Aside
from pursuing these specific questions in the context of
patient-oriented clinical trials, implementation of any find-
ings remains a further challenge for overburdened local
health systems. Operational research on the best means
of implementing these findings and how efficacious these
findings would be in practice would thus also be useful in
order to inform the most cost-effective therapy for HIV-
infected children with malnutrition.
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